Use of synthetic peptides to establish anti-human acetylcholine receceptor CD4 + cell lines from myasthenia gravis patients

Maria Pia Protti, Angelo A. Manfredi, Christi Straub, Xiaodong Wu, James F. Howard, Bianca M. Conti-Tronconi

Research output: Contribution to journalArticle

Abstract

Acetylcholine receptor-(AcChR) specific T cell lines were propagated from the PBL of six myasthenia gravis (MG) patients by the use of a pool of synthetic peptides (α-pool) corresponding to the complete sequence of the α-subunit of the human AcChR. All the lines had CD4+ phenotype and strongly recognized the α-pool. Four lines crossreacted with native Torpedo AcChR. Five lines showed, at certain stages of their propagation, some degree of reactivity to autologous or DR-matched APC. One of the CD4+ T lines was challenged with each one of the peptides present in the α-pool. Several peptides, corresponding to the sequence segments 48-67, 101-120, 304-322, 320-337, and 419-437 of the human α-subunit were recognized, indicating that different epitopes and multiple T cell clones are involved in the recognition of the autoantigen in MG. Human AcChR-specific CD4+ T cell lines will be useful to identify the repertoire of epitopes recognized by the autoreactive Th cells in MG, to investigate the TCR genes utilized by autoreactive Th cells and to develop specific immunosuppressive treatments using anti-T cell vaccination.

Original languageEnglish
Pages (from-to)1711-1720
Number of pages10
JournalJournal of Immunology
Volume144
Issue number5
Publication statusPublished - Mar 1 1990

ASJC Scopus subject areas

  • Immunology

Fingerprint Dive into the research topics of 'Use of synthetic peptides to establish anti-human acetylcholine receceptor CD4 + cell lines from myasthenia gravis patients'. Together they form a unique fingerprint.

  • Cite this